John Gillen
John Gillen considers himself the 'European pioneer' of NAD+ therapy and operates several clinics registered with the Care Quality Commission. He has been involved in numerous NAD+ infusions and acknowledges the need for better regulation and clarity regarding its use in addiction treatment.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 5.00 | 0.03% | +0% | 67,886,011 | 18,293 | $2,700,000 | 728$ |
| Totals | 1 | 67,886,011 | 18,293 | $2,700,000 | 728$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
John Gillen, who calls himself the 'European pioneer' of NAD+, has been involved in numerous NAD+ infusions.
5